Biogen, Inc. (BIIB)
222.65
+6.61
(+3.06%)
USD |
NASDAQ |
Sep 02, 16:00
222.65
0.00 (0.00%)
After-Hours: 19:41
Biogen Research and Development Expense (TTM) : 1.736B for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.736B |
| March 31, 2026 | 1.607B |
| December 31, 2025 | 1.498B |
| September 30, 2025 | 1.524B |
| June 30, 2025 | 1.624B |
| March 31, 2025 | 1.734B |
| December 31, 2024 | 1.755B |
| September 30, 2024 | 1.803B |
| June 30, 2024 | 2.005B |
| March 31, 2024 | 2.083B |
| December 31, 2023 | 2.208B |
| September 30, 2023 | 2.237B |
| June 30, 2023 | 2.050B |
| March 31, 2023 | 1.992B |
| December 31, 2022 | 1.959B |
| September 30, 2022 | 2.055B |
| June 30, 2022 | 2.207B |
| March 31, 2022 | 2.276B |
| December 31, 2021 | 2.266B |
| September 30, 2021 | 3.308B |
| June 30, 2021 | 3.760B |
| March 31, 2021 | 3.826B |
| December 31, 2020 | 3.789B |
| September 30, 2020 | 2.760B |
| June 30, 2020 | 2.211B |
| Date | Value |
|---|---|
| March 31, 2020 | 2.100B |
| December 31, 2019 | 2.235B |
| September 30, 2019 | 2.200B |
| June 30, 2019 | 2.168B |
| March 31, 2019 | 2.664B |
| December 31, 2018 | 2.597B |
| September 30, 2018 | 2.573B |
| June 30, 2018 | 2.512B |
| March 31, 2018 | 2.327B |
| December 31, 2017 | 2.254B |
| September 30, 2017 | 2.200B |
| June 30, 2017 | 2.282B |
| March 31, 2017 | 1.959B |
| December 31, 2016 | 1.973B |
| September 30, 2016 | 1.981B |
| June 30, 2016 | 1.972B |
| March 31, 2016 | 1.990B |
| December 31, 2015 | 2.013B |
| September 30, 2015 | 1.971B |
| June 30, 2015 | 1.869B |
| March 31, 2015 | 1.825B |
| December 31, 2014 | 1.893B |
| September 30, 2014 | 1.816B |
| June 30, 2014 | 1.808B |
| March 31, 2014 | 1.689B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | 923.08M |
| AbbVie, Inc. | 9.714B |
| Regeneron Pharmaceuticals, Inc. | 5.748B |
| Vertex Pharmaceuticals, Inc. | 3.907B |
| Amgen, Inc. | 7.638B |